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Supplementary Figure 1. Localization of Htl, AJ protein E-Cad, β-Cat and fluorescent 
protein-tagged Baz with alternative antibodies. 
(A-C) Immunostaining of embryos carrying a htl-mcherry transgene at stage 7 (A), stage 9 (B), 
or stage 10 (C) using an anti-RFP antibody. 
(D-I) Colocalization using anti-β-Cat (green), anti-E-Cad (red) and anti-Htl (blue) in embryos of 
stage 6 (D), stage 7 early (E), stage 7 late (F), stage 8 early (G), stage 8 late, and stage 9 (I).  
(J-L) Baz (red) fluorescent immunostaining in stage 10 control (J), htl M+Z- (K) and twih-pyr (L) 
embryos. Embryos were co-stained with Nrt (light grey) to visualize the cellular morphology. 
Confocal single scans shown were taken from manually cross-sectioned embryos. 
(M-N) Quantification of Baz expression in J-L. Total number of Baz puncta in the mesoderm is 
significantly decreased in htl M+Z- mutants, but increased in twih>ths embryos compared to the 
control (asterisks, M, p<0.001). Percentage of apically localized Baz puncta is decreased in both 
mutants (asterisks, N, p<0.001). Numbers of embryos for each genetic background at stage 10 
are as following (total number of the confocal scans is indicated inside the parenthesis): control: 
3(5); htlM+Z-: 3(3); twih>ths: 7(7). Confocal scans were taken under the same setting. Baz puncta 
were counted with the same threshold in Image J. Student t-test was used to test significance. 
Error bars represent s.d.  
(O-Q) Immunostaining of embryos expressing baz-GFP driven by twih-GAL4 with anti-Baz 
antibody at stage 8 early (O), stage 8 late (P), and stage 10 (Q). 
(R-T) Immunostaining of embryos expressing baz-RFP by the same driver, with anti-RFP 
antibody at stage 8 early (R), stage 8 late (S), and stage 9/10 (T). 





















Supplementary Figure 2. Mys and Baz levels in the mesoderm are regulated by FGF. 
(A-H,K,L,N-Q,S,T) Stage 10 embryos of the indicated genotypes immunostained using 
antibodies against Mys (A,D,G,K,N,P,S and magnified views of boxed regions in 
A’,D’,G’,K’,N’,P’,S’), Twi (B,E,H,L,O,Q,T) or Baz (C,F and magnified views of boxed regions 
in C’,F’). Number of st10 embryos analyzed by Twi antibody staining is indicated at the bottom 
right corner in B, E, H, L, O, Q and T. Ratios, if given, represent percentage showing phenotype. 





















(I, J) Expression of mys transcripts detected by in situ hybridization using a riboprobe in control 
and htlM-Z- mutant embryos around stage 9. mys expression is identified in the ectoderm, 
mesoderm as well as endoderm.  
(M) Quantification of relative Baz enrichment in the mesoderm in C’ and F’ compared to the 
control (see Fig 4A,B).  
(R) Quantification of relative Mys enrichment in the mesoderm-ectoderm interface in A’, D’, G’, 
K’, N’, P’, S’ compared to the control (see Fig 5A’,Q).  
Number of embryos used for statistical analysis is indicated underneath the genotype with the 
number of sections inside the parenthesis. Error bars represent s.d. Asterisks represent datapoints 
that are significantly different from the control based on student t-test (p<0.05). 





















Supplementary Figure 3. Calculation of the mesoderm spreading profile in control, 
twih>ths and twih>baz RNAi mutant embryos.  
(A) Schematic showing how azimuthal angular position changes upon normal spreading 
movement of cells. 





















(B-D) Representative stills at the indicated times from movies of embryos of control (B: twi-
Gal4 x yw), ectopically expressing Ths ligand in the mesoderm (C: twih-Gal4 x UAS.ths) and 
knocking down baz in the mesoderm (D: twih-Gal4 x UAS.baz.RNAi) that also contain the H2A-
GFP transgene, which allows visualization of mesoderm cells throughout the course of their 
migration by live in vivo imaging. 
(E-G) Plots of azimuthal angular position, θstart vs. θend, for tracked mesoderm cells in (B), (C) 
and (D). In control embryo, the slope of the line, A, is close to 2 and has been previously used to 
define the degree of collective movement of mesoderm cells (McMahon et al., 2008). Upon 
ectopic expression of Ths, A is reduced to 1 (F), demonstrating that cells do not spread as θstart is 
equivalent to θend. In a less severe twih>baz RNAi embryo that has been tracked (G), A falls 
between 1 and 2 (θend is less than twice θstart, as found in the control), suggesting spreading is 
compromised without Baz participation. 
(H-J) See supplemental movie 4. Tracking analysis of the twih>baz RNAi embryo with a mild 
spreading phenotype (D,G) displayed in a similar manner to the control (Figure 7F,I,L). 	





















Supplementary Figure 4. Example of calculating the enrichment of colocalized α-Catenin 
and β-Catenin in the mesoderm. Z-projections from confocal scans of stg embryos co-stained 
by antibodies against α-Catenin (violet) and β-Catenin (green) at stage7 (A) and stage10 (B). 
Boxes in white indicate the mesoderm signal while boxes in yellow of the same size indicate the 
ectoderm signal. Gray value measurements were taken for both in Image J. The relative 
enrichment was calculated by dividing the value in white box by the value in yellow box. 






















Movie 1 shows mesoderm cell spreading in an embryo containing an H2A-GFP transgene that 
allows tracking of cell movement in yw background. 
Movie 2 shows mesoderm cell spreading in a twih>ths mutant embryo containing the H2A-GFP 
transgene. 





















Movie 3 shows mesoderm cell spreading in twih>baz RNAi mutant background, carrying H2A-
GFP transgene, that exhibits defects as early as invagination (likely “strong” phenotype)..  
Movie 4 shows mesoderm cell spreading in an H2A-GFP transgenic embryo in twih>baz RNAi 
mutant background that exhibits normal invagination but mild spreading defect later (likely 
“mild” phenotype). 
Development: doi:10.1242/dev.161927: Supplementary information
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